Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for NovelStem International Corp. (NSTM : OTC)

• Company Description    NovelStem International Corp. is a biotechnology company. It focuses on the development of chemotherapy treatments for genetic disorders and cancer patients. NovelStem International Corp., formerly known as Hollywood Media Corp., is based in Boca Raton, United States. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.01 Daily Weekly Monthly 20 Day Moving Average: 81,463 shares Shares Outstanding: 46.88 (millions) Market Capitalization: $0.42 (millions) Beta: 2.25 52 Week High: $0.04 52 Week Low: $0.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -49.72% -49.63% 12 Week -50.00% -50.81% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2255 GLADES RD SUITE 221A - BOCA RATON,FL 33431 USA ph: 410-598-9024 fax: 561-998-2974 nstm@catalyst-ir.com http://www.novelstem.com

• General Corporate Information    Officers Jan H. Loeb - President and Executive Chairman Christine Jenkins - Vice President and Chief Financial Officer Mitchell Rubenstein - Director Eric Richman - Director David Seltzer - Director Peer Information NovelStem International Corp. (CORR.) NovelStem International Corp. (RSPI) NovelStem International Corp. (CGXP) NovelStem International Corp. (BGEN) NovelStem International Corp. (GTBP) NovelStem International Corp. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 67001V109 SIC: 5990 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/06/26 Share - Related Items Shares Outstanding: 46.88 Most Recent Split Date: (:1) Beta: 2.25 Market Capitalization: $0.42 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 0.15 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 35.16 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: 0.00% ROE 12/31/25 - - 09/30/25 - -63.58 06/30/25 - - ROA 12/31/25 - - 09/30/25 - 2,712.21 06/30/25 - -61.08 Current Ratio 12/31/25 - - 09/30/25 - 0.01 06/30/25 - 0.01 Quick Ratio 12/31/25 - - 09/30/25 - 0.01 06/30/25 - 0.01 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - 22,460.66 06/30/25 - -450.00 Book Value 12/31/25 - - 09/30/25 - -0.04 06/30/25 - -0.04 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©